DRONIVIA PHARMA
Cannabidiol API
Pharmaceutical-Grade Cannabidiol API for B2B Applications
We supply Cannabidiol (CBD) API for qualified pharmaceutical manufacturers, formulation developers, distributors and other permitted B2B applications, subject to the product classification and regulatory requirements in the destination market. Professional buyers can request product-specific specifications and available quality documentation to assess whether the material meets their intended-use requirements.
Our Cannabidiol API offering supports professional customers with product-specific technical and quality documentation. This information can help pharmaceutical manufacturers, distributors and other qualified organisations evaluate material identity, quality attributes, traceability and suitability as part of their procurement and supplier-qualification processes.
Whether you are evaluating CBD API for a permitted formulation, manufacturing process or ongoing commercial supply, our B2B service focuses on documentation, transparent communication and confirmation of product-specific specifications, packaging options and supply requirements. Contact our team to discuss the documentation available for the material you are considering.
Specifications
Technical Specifications for Pharmaceutical Cannabidiol API
For professional procurement, the CBD API specification is an important part of supplier qualification and quality assessment. Product-specific technical documentation enables qualified B2B customers to evaluate the material against their intended application and applicable requirements.
Cannabidiol API at a Glance
This page outlines information typically reviewed when assessing Cannabidiol API as an active ingredient or pharmaceutical starting material. Depending on the product and intended use, buyers may review identity, assay, purity, related substances, residual solvents, other relevant impurities, storage conditions and supporting documentation. The exact parameters and acceptance criteria must be taken from the current, approved specification for the product being offered.
Parameter
Specification / information
Active ingredient
Cannabidiol (CBD)
Identity
According to the approved product specification
Assay and purity
Current acceptance criteria available on request
Related substances
According to the approved product specification
Residual solvents
Product-specific limits available on request
Other relevant impurities
Depending on the product and intended use
Storage conditions
According to the current product specification
Quality documentation
Current specification and available batch documentation on request
Specifications and Certificate of Analysis (CoA)
The product specification defines the applicable quality requirements, while the Certificate of Analysis (CoA) records analytical results for an individual batch. Qualified B2B customers should review these documents together as part of supplier qualification and incoming quality assessment.
The Current Cannabidiol API Specifications
Specifications may differ by product, manufacturer, grade and intended application. Contact our team for the current controlled specification, applicable test methods and technical documentation available for the specific Cannabidiol API material. Acceptance criteria should always be assessed against the approved product specification and the customer’s requirements.
Certificate of Analysis (CoA)
Cannabidiol API CoA and Batch Quality Documentation
A Certificate of Analysis (CoA) provides batch-specific analytical information that professional procurement and quality teams can use to assess a supplied batch against the applicable product specification.
Relevant quality documentation for CBD API should be reviewed in conjunction with the approved specification, the intended use and the quality requirements applicable to the customer and destination market.
What Is a Cannabidiol API CoA?
A Certificate of Analysis documents test results for a specific batch of Cannabidiol. Depending on the product and its controlled specification, the CoA may include:
Product name and grade
Batch or lot number
Manufacturer and relevant manufacturing information
Date of manufacture, where applicable
Retest or expiry date, as applicable
Applicable specification and test methods
Identification results
Assay or content
Purity and related substances
Residual solvents and other relevant impurity tests
Other product-specific analytical tests
Release or approval information, where applicable
The exact contents depend on the product specification, the testing programme and the applicable quality system.
Why Is a CoA Important for Cannabidiol API?
Professional buyers need to assess whether the supplied material meets defined quality requirements for its intended use. A CoA supports this assessment but should not be treated, by itself, as proof of regulatory authorisation, suitability for every application or compliance with every customer requirement.
Request Cannabidiol API Batch Documentation
If you are evaluating Cannabidiol API as an ingredient or pharmaceutical starting material, contact our team to request the current product specification and available batch documentation for the relevant material. Please share your intended application and destination market so that applicable product information can be identified.
Cannabidiol API GMP
GMP and Pharmaceutical-Quality Cannabidiol API
Good Manufacturing Practice (GMP) and the applicable quality system are important considerations when sourcing materials for regulated pharmaceutical applications. Depending on the intended use and market, buyers may need to assess the manufacturing site, supplier qualification, batch documentation, change-control arrangements and applicable regulatory requirements. Any GMP-related statement should be supported by current, relevant evidence for the specific site and supply chain.
Documentation and quality claims should be specific to the product and supply chain. Do not describe a product or manufacturing site as GMP-compliant unless the relevant status is supported by current, verifiable documentation.
Cannabidiol API GMP Documentation
Depending on the product and supply arrangement, professional customers may request or assess documentation such as:
GMP certificate or other applicable quality-system evidence, where available and relevant
Manufacturing-site information
Current product specification
Certificate of Analysis
Batch-specific documentation
Quality agreement, where applicable
Supplier qualification information
Storage, handling and transportation requirements
Information on product classification and intended-use limitations
GMP and German Pharmacy Requirements
The regulatory status of CBD-containing materials and the requirements for their supply or use can vary according to product characteristics, intended use and jurisdiction. Customers should confirm the relevant legal and regulatory requirements before qualification, purchase or use. Avoid implying that one documentation package automatically establishes suitability in every market or application.
Cannabidiol API GMP Information
If your organisation is evaluating Cannabidiol API for a regulated or other qualified application, contact our team for current product information and the quality documentation available for the specific material. Any assessment of GMP status or regulatory suitability should be based on relevant, current documentation and the requirements of the destination market.
Cannabidiol API for Pharmaceutical Manufacturers and Pharmacies
Pharmaceutical manufacturers, pharmacies and other qualified B2B buyers evaluating Cannabidiol API need product information that helps them assess quality, documentation, traceability and suitability for the intended application. Relevant details may include the current product specification, batch-specific Certificate of Analysis (CoA), available quality-system documentation, storage and handling requirements, packaging information and supply conditions. Requirements vary by product and destination market, so suitability should be confirmed for each intended use.
Cannabidiol API as a Pharmaceutical Starting Material
Cannabidiol (CBD) Active Pharmaceutical Ingredient (API) may be used as a pharmaceutical starting material in the development and manufacture of medicinal products where its use is permitted and the applicable requirements are met. Its suitability depends on product-specific quality attributes, including identity, assay, purity, related substances and control of relevant impurities, as defined in the approved specification. Buyers should review appropriate analytical methods, batch-specific results, traceability, storage conditions and supporting quality documentation. Manufacturing controls and supplier qualification help assess batch-to-batch consistency, while regulatory status and documentation requirements must be confirmed for the intended product and destination market.
What Pharmaceutical Buyers Need from a Cannabidiol API Supplier
During supplier qualification and procurement, pharmaceutical manufacturers, pharmacies and other professional buyers may consider:
Product quality: whether the material meets the approved specification and the customer's applicable requirements
Certificate of Analysis: availability of batch-specific analytical results
Identity and testing: appropriate methods and acceptance criteria for the intended use
Quality-system information: relevant manufacturing and quality documentation, where applicable
Traceability: clear batch identification and supporting records
Storage and handling: documented conditions appropriate to the product
Regulatory suitability: assessment of the product and intended use in the destination market
Supply requirements: available pack sizes, lead times and commercial terms confirmed by the supplier
Cannabidiol API Supplier for Pharmaceutical Manufacturers and Pharmacies
Qualified customers may contact our team to discuss:
CBD API and product-specific specifications
Available CoA and batch information
Quality and technical documentation
Packaging options confirmed for the product
Supply availability and commercial quotations
Technical questions related to the documented product
Request Cannabidiol API Product Information
Please provide your organisation details, intended application, required quantity, destination market and documentation requirements. Our B2B team can then confirm the product information, available specifications and batch documentation, packaging options, supply availability and commercial terms relevant to the material under consideration.
Dronabinol API
Dronivia offers Dronabinol API for qualified B2B customers, including pharmacy and pharmaceutical use where applicable. Contact our team to discuss product specifications, available documentation, and supply requirements.
View Dronabinol API →
CBD Extract
CBD extracts for professional use by qualified customers, subject to product availability and applicable regulatory requirements.
View CBD Extract →
Standardized Extracts
Extracts with defined cannabinoid profiles, supporting consistency, traceability and professional evaluation for relevant applications.
View standardized extracts →